Top

Published in:

Open Access 01-06-2012 | Esophagus (MF Vela, Section Editor)

Clinical Applications of Esophageal Impedance Monitoring and High-Resolution Manometry

Authors: Boudewijn F. Kessing, André J. P. M. Smout, Albert J. Bredenoord

Published in: Current Gastroenterology Reports | Issue 3/2012

Abstract

Esophageal impedance monitoring and high-resolution manometry (HRM) are useful tools in the diagnostic work-up of patients with upper gastrointestinal complaints. Impedance monitoring increases the diagnostic yield for gastroesophageal reflux disease in adults and children and has become the gold standard in the diagnostic work-up of reflux symptoms. Its role in the work-up for belching disorders and rumination seems promising. HRM is superior to other diagnostic tools for the evaluation of achalasia and contributes to a more specific classification of esophageal disorders in patients with non-obstructive dysphagia. The role of HRM in patients with dysphagia after laparoscopic placement of an adjustable gastric band seems promising. Future studies will further determine the clinical implications of the new insights which have been acquired with these techniques. This review aims to describe the clinical applications of impedance monitoring and HRM.

Butin JW, Olsen AM, Moersch HJ, Code CF. A study of esophageal pressures in normal persons and patients with cardiospasm. Gastroenterology. 1953;23(2):278–93.PubMed

Dent J. A new technique for continuous sphincter pressure measurement. Gastroenterology. 1976;71(2):263–7.PubMed

Clouse RE, Staiano A. Topography of the esophageal peristaltic pressure wave. Am J Physiol. 1991;261(4 Pt 1):G677–84.PubMed

Grübel C, Hiscock R, Hebbard G. Value of spatiotemporal representation of manometric data. Clin Gastroenterol Hepatol. 2008;6(5):525–30.PubMedCrossRef

Johnson LF, Demeester TR. Twenty-four-hour pH monitoring of the distal esophagus. A quantitative measure of gastroesophageal reflux. Am J Gastroenterol. 1974;62(4):325–32.PubMed

Silny J. Intraluminal multiple electric impedance procedure for measurement of gastrointestinal motility. J Gastrointest Motil. 1991;3:151–62.

Tuttle SG, Grossman MI. Detection of gastro-esophageal reflux by simultaneous measurement of intraluminal pressure and pH. Proc Soc Exp Biol Med. 1958;98(2):225–7.PubMed

Spechler SJ, Castell DO. Classification of oesophageal motility abnormalities. Gut. 2001;49(1):145–51.PubMedCrossRef

Pandolfino JE, Ghosh SK, Rice J, et al. Classifying esophageal motility by pressure topography characteristics: a study of 400 patients and 75 controls. Am J Gastroenterol. 2008;103(1):27–37.PubMed

10.

Ghosh SK, Pandolfino JE, Rice J, et al. Impaired deglutitive EGJ relaxation in clinical esophageal manometry: a quantitative analysis of 400 patients and 75 controls. Am J Physiol Gastrointest Liver Physiol. 2007;293(4):G878–85.PubMedCrossRef

11.

Pandolfino JE, Fox MR, Bredenoord AJ, Kahrilas PJ. High-resolution manometry in clinical practice: utilizing pressure topography to classify oesophageal motility abnormalities. Neurogastroenterol Motil. 2009;21(8):796–806.PubMedCrossRef

12.

Roman S, Lin Z, Pandolfino JE, Kahrilas PJ. Distal contraction latency: a measure of propagation velocity optimized for esophageal pressure topography studies. Am J Gastroenterol. 2011;106(3):443–51.PubMedCrossRef

13.

Pandolfino JE, Leslie E, Luger D, et al. The contractile deceleration point: an important physiologic landmark on oesophageal pressure topography. Neurogastroenterol Motil. 2010;22(4):395–400. e90.PubMedCrossRef

14.

Pandolfino JE, Roman S, Carlson D, et al. Distal esophageal spasm in high-resolution esophageal pressure topography: defining clinical phenotypes. Gastroenterology. 2011;141(2):469–75.PubMedCrossRef

15.

Bogte A, Bredenoord AJ, Oors J, Siersema PD, Smout AJPM. Reproducibility of esophageal high-resolution manometry. Neurogastroenterol Motil. 2011;23(7):e271–6.PubMedCrossRef

16.

Fox M, Hebbard G, Janiak P, et al. High-resolution manometry predicts the success of oesophageal bolus transport and identifies clinically important abnormalities not detected by conventional manometry. Neurogastroenterol Motil. 2004;16(5):533–42.PubMedCrossRef

17.

Ghosh SK, Pandolfino JE, Kwiatek MA, Kahrilas PJ. Oesophageal peristaltic transition zone defects: real but few and far between. Neurogastroenterol Motil. 2008;20(12):1283–90.PubMedCrossRef

18.

• Roman S, Lin Z, Kwiatek MA, Pandolfino JE, Kahrilas PJ. Weak peristalsis in esophageal pressure topography: classification and association with Dysphagia. Am J Gastroenterol. 2011;106(2):349–56. This article defines novel criteria for the peristaltic pressure breaks and correlates these findings to the clinical presentation of the patient..PubMedCrossRef

19.

Bredenoord AJ, Weusten BLAM, Carmagnola S, Smout AJPM. Double-peaked high-pressure zone at the esophagogastric junction in controls and in patients with a hiatal hernia: a study using high-resolution manometry. Dig Dis Sci. 2004;49(7–8):1128–35.PubMedCrossRef

20.

Scherer JR, Kwiatek MA, Soper NJ, Pandolfino JE, Kahrilas PJ. Functional esophagogastric junction obstruction with intact peristalsis: a heterogeneous syndrome sometimes akin to achalasia. J Gastrointest Surg. 2009;13(12):2219–25.PubMedCrossRef

21.

• Lazarescu A, Karamanolis G, Aprile L, et al. Perception of dysphagia: lack of correlation with objective measurements of esophageal function. Neurogastroenterol Motil. 2010;22(12):1292–7. This article highlights the lack of correlation between objective findings and subjective complaints in patients with non-obstructive dysphagia..PubMedCrossRef

22.

Pandolfino JE, Kwiatek MA, Nealis T, et al. Achalasia: a new clinically relevant classification by high-resolution manometry. Gastroenterology. 2008;135(5):1526–33.PubMedCrossRef

23.

Hong SJ, Bhargava V, Jiang Y, Denboer D, Mittal RK. A unique esophageal motor pattern that involves longitudinal muscles is responsible for emptying in achalasia esophagus. Gastroenterology. 2010;139(1):102–11.PubMedCrossRef

24.

Pratap N, Kalapala R, Darisetty S, et al. Achalasia cardia subtyping by high-resolution manometry predicts the therapeutic outcome of pneumatic balloon dilatation. J Neurogastroenterol Motil. 2011;17(1):48–53.PubMedCrossRef

25.

Burton PR, Brown WA, Laurie C, Hebbard G, O’Brien PE. Criteria for assessing esophageal motility in laparoscopic adjustable gastric band patients: the importance of the lower esophageal contractile segment. Obes Surg. 2010;20(3):316–25.PubMedCrossRef

26.

Cruiziat C, Roman S, Robert M, et al. High resolution esophageal manometry evaluation in symptomatic patients after gastric banding for morbid obesity. Dig Liver Dis. 2011;43(2):116–20.PubMedCrossRef

27.

Roman S, Hirano I, Kwiatek MA, et al. Manometric features of eosinophilic esophagitis in esophageal pressure topography. Neurogastroenterol Motil. 2011;23(3):208–14. e111.PubMedCrossRef

28.

Aanen MC, Bredenoord AJ, Samsom M, Smout AJPM. Reliability of oesophageal pH recording for the detection of gastro-oesophageal reflux. Scand J Gastroenterol. 2008;43(12):1442–7.PubMedCrossRef

29.

Bredenoord AJ, Weusten BLAM, Timmer R, Conchillo JM, Smout AJPM. Addition of esophageal impedance monitoring to pH monitoring increases the yield of symptom association analysis in patients off PPI therapy. Am J Gastroenterol. 2006;101(3):453–9.PubMedCrossRef

30.

Savarino E, Marabotto E, Zentilin P, et al. The added value of impedance-pH monitoring to Rome III criteria in distinguishing functional heartburn from non-erosive reflux disease. Dig Liver Dis. 2011;43(7):542–7.PubMedCrossRef

31.

Hemmink GJ, Bredenoord AJ, Weusten BL, et al. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: ‘on’ or ‘off’ proton pump inhibitor? Am J Gastroenterol. 2008;103(10):2446–53.PubMedCrossRef

32.

Broeders JAJL, Bredenoord AJ, Hazebroek EJ, et al. Effects of anti-reflux surgery on weakly acidic reflux and belching. Gut. 2011;60(4):435–41.PubMedCrossRef

33.

Ip S, Tatsioni A, Conant A, et al. Predictors of clinical outcomes following fundoplication for gastroesophageal reflux disease remain insufficiently defined: a systematic review. Am J Gastroenterol. 2009;104(3):752–8.PubMedCrossRef

34.

Broeders JA, Draaisma WA, Bredenoord AJ, et al. Impact of symptom-reflux association analysis on long-term outcome after Nissen fundoplication. Br J Surg. 2011;98(2):247–54.PubMedCrossRef

35.

Kessing BF, Bredenoord AJ, Weijenborg PW, et al. Esophageal acid exposure decreases intraluminal baseline impedance levels. Am J Gastroenterol. 2011;106(12):2093–7.PubMedCrossRef

36.

Loots CM, van Wijk MP, Smits MJ. Measurement of mucosal conductivity using multichannel intraluminal impedance: a potential marker of mucosal integrity that is restored in infants receiving acid suppression therapy. J Pediatr Gastroenterol Nutr. 2011;53(1):120–3.PubMedCrossRef

37.

• Farré R, Blondeau K, Clement D, et al. Evaluation of oesophageal mucosa integrity by the intraluminal impedance technique. Gut. 2011;60(7):885–92. This article assesses whether the baseline impedance level can be a novel marker for esophageal mucosa integrity..PubMedCrossRef

38.

Loots CM, van Wijk MP, Blondeau K, et al. Inter- and intra observer variability in pH-impedance analysis between 10 experts and automated analysis. J Pediatr. http://dx.doi.org/10.1016/j.jpeds.2011.08.017.

39.

Hemmink GJM, Bredenoord AJ, Aanen MC. Computer analysis of 24-h esophageal impedance signals. Scand J Gastroenterol. 2011;46(3):271–6.PubMedCrossRef

40.

Bredenoord A, Smout A. Physiologic and pathologic belching. Clin Gastroenterol Hepatol. 2007;5(7):772–5.PubMedCrossRef

41.

Wyman JB, Dent J, Heddle R, et al. Control of belching by the lower oesophageal sphincter. Gut. 1990;31(6):639–46.PubMedCrossRef

42.

Bredenoord AJ, Weusten BLAM, Sifrim D, Timmer R, Smout AJPM. Aerophagia, gastric, and supragastric belching: a study using intraluminal electrical impedance monitoring. Gut. 2004;53(11):1561–5.PubMedCrossRef

43.

Hemmink GJM, Ten Cate L, Bredenoord AJ, et al. Speech therapy in patients with excessive supragastric belching–a pilot study. Neurogastroenterol Motil. 2010;22(1):24–8. e2-3.PubMed

44.

Hemmink GJM, Bredenoord AJ, Weusten BLAM, Timmer R, Smout AJPM. Supragastric belching in patients with reflux symptoms. Am J Gastroenterol. 2009;104(8):1992–7.PubMedCrossRef

45.

Hemmink GJM, Weusten BLAM, Bredenoord AJ, Timmer R, Smout AJPM. Aerophagia: excessive air swallowing demonstrated by esophageal impedance monitoring. Clin Gastroenterol Hepatol. 2009;7(10):1127–9.PubMedCrossRef

46.

van Wijk MP, Benninga MA, Omari TI. Role of the multichannel intraluminal impedance technique in infants and children. J Pediatr Gastroenterol Nutr. 2009;48(1):2–12.PubMedCrossRef

47.

• Pilic D, Fröhlich T, Nöh F, et al. Detection of gastroesophageal reflux in children using combined multichannel intraluminal impedance and pH measurement: data from the German Pediatric Impedance Group. J Pediatr. 2011;158(4):650–4.e1. This article describes the use of impedance monitoring in children and demonstrates that pH-impedance monitoring is superior to pH-metry alone.

48.

Loots CM, Benninga MA, Davidson GP, Omari TI. Addition of pH-impedance monitoring to standard pH monitoring increases the yield of symptom association analysis in infants and children with gastroesophageal reflux. J Pediatr. 2009;154(2):248–52.PubMedCrossRef

49.

Rosen R, Levine P, Lewis J, Mitchell P, Nurko S. Reflux events detected by pH-MII do not determine fundoplication outcome. J Pediatr Gastroenterol Nutr. 2010;50(3):251–5.PubMedCrossRef

50.

Foundation R. Guidelines–Rome III diagnostic criteria for functional gastrointestinal disorders. J Gastrointestin Liver Dis. 2006;15(3):307–12.

51.

Tack J, Blondeau K, Boecxstaens V, Rommel N. Review article: the pathophysiology, differential diagnosis and management of rumination syndrome. Aliment Pharmacol Ther. 2011;33(7):782–8.PubMedCrossRef

52.

Kessing BF, Govaert F, Masclee AAM, Conchillo JM. Impedance measurements and high-resolution manometry help to better define rumination episodes. Scand J Gastroenterol. 2011;46(11):1310–5.PubMedCrossRef

53.

Rommel N, Tack J, Arts J, et al. Rumination or belching-regurgitation? Differential diagnosis using oesophageal impedance-manometry. Neurogastroenterol Motil. 2010;22(4):e97–104.PubMedCrossRef

54.

Conchillo JM, Nguyen NQ, Samsom M, Holloway RH, Smout AJPM. Multichannel intraluminal impedance monitoring in the evaluation of patients with non-obstructive Dysphagia. Am J Gastroenterol. 2005;100(12):2624–32.PubMedCrossRef

55.

Burgess NG, Wyeth JW. An audit of combined multichannel intraluminal impedance manometry in the assessment of dysphagia. J Gastroenterol Hepatol. 2011;26:79–82.PubMedCrossRef

56.

Kwiatek MA, Pandolfino JE, Kahrilas PJ. 3D-high resolution manometry of the esophagogastric junction. Neurogastroenterol Motil. 2011;23(11):e461–9.PubMedCrossRef

57.

Pritchett JM, Aslam M, Slaughter JC, Ness RM, Garrett CG, Vaezi MF. Efficacy of esophageal impedance/pH monitoring in patients with refractory gastroesophageal reflux disease, on and off therapy. Clin Gastroenterol Hepatol. 2009;7(7):743–8.PubMedCrossRef

58.

Pandolfino JE, Vela MF. Esophageal-reflux monitoring. Gastrointest Endosc. 2009;69(4):917–30.PubMedCrossRef

Title: Clinical Applications of Esophageal Impedance Monitoring and High-Resolution Manometry
Authors: Boudewijn F. Kessing
André J. P. M. Smout
Albert J. Bredenoord
Publication date: 01-06-2012
Publisher: Current Science Inc.
Published in: Current Gastroenterology Reports / Issue 3/2012
Print ISSN: 1522-8037
Electronic ISSN: 1534-312X
DOI: https://doi.org/10.1007/s11894-012-0253-9

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2012

Clinical Implications of Molecular Changes in Pediatric Barrett’s Esophagus

Portal Vein Complications after Pediatric Liver Transplantation

Management and Prognosis of Acute Liver Failure in Children

Update on Fundoplication for the Treatment of GERD

Advanced Endoscopic Imaging for Barrett’s Esophagus: Current Options and Future Directions

Medical Update and Potential Advances in the Treatment of Pediatric Intestinal Failure

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials